Hiromichi Katayama
Overview
Explore the profile of Hiromichi Katayama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shiraiwa T, Katayama H, Iwasaki Y, Kimura S, Satake Y, Sato T, et al.
IJU Case Rep
. 2024 Jul;
7(4):285-288.
PMID: 38966768
Introduction: Choriocarcinoma syndrome with multiple lung metastases has a poor prognosis and causes respiratory failure due to alveolar hemorrhage. We encountered a case where the introduction of extracorporeal membrane oxygenation...
2.
Sato Y, Kawasaki Y, Satake Y, Shimoda Y, Katayama H, Sato T, et al.
Case Rep Oncol
. 2023 Dec;
16(1):1573-1578.
PMID: 38089733
Although the response to combination therapy has been reported in patients with brain metastases from advanced renal cancer, treatment-related cerebral hemorrhage has not been adequately studied. The CheckMate 9ER clinical...
3.
Kimura S, Katayama H, Ohara E, Aoki H, Shibuya R, Naganuma H, et al.
Int J Urol
. 2023 Oct;
31(1):82-87.
PMID: 37803911
Objectives: To investigate who needs a careful postoperative monitoring for prostate cancer (PCa) after holmium laser enucleation of the prostate (HoLEP). We examined characteristics and oncological outcomes of HoLEP-related PCa....
4.
Nakagawa T, Kawasaki Y, Sato S, Katayama H, Satake Y, Shimada S, et al.
Case Rep Oncol
. 2023 Jan;
15(3):1014-1020.
PMID: 36636673
In a rare case, free from systemic therapy, deferred cytoreductive nephrectomy was implemented in treating an advanced renal cell carcinoma with liver, lung, and splenic colon metastases. A 59-year-old man...
5.
Nezu K, Kawasaki Y, Morimoto R, Ono Y, Omata K, Tezuka Y, et al.
Tohoku J Exp Med
. 2023 Jan;
259(3):229-236.
PMID: 36596503
Poor prognostic cardiac function is known among some patients with primary aldosteronism (PA). However, studies with echocardiograms on whether the normalization of aldosterone after laparoscopic adrenalectomy (LADX) improves myocardial hypertrophy...
6.
Saijo K, Imai H, Katayama H, Fujishima F, Nakamura K, Kasahara Y, et al.
Case Rep Oncol
. 2022 Sep;
15(2):762-769.
PMID: 36157689
An 18-year-old Japanese man was diagnosed with an undifferentiated sarcoma of the spermatic cord, with multiple distant metastases to the lungs and bones. The patient received doxorubicin-based standard chemotherapy. Although...
7.
Chiba D, Kawasaki Y, Miyagi A, Katsumata Y, Satake Y, Shimada S, et al.
Tohoku J Exp Med
. 2022 Apr;
257(2):127-133.
PMID: 35418533
The present case study was conducted on a 74-year-old man who visited our department due to a left renal and retroperitoneal tumor on computed tomography (CT). The patient was diagnosed...
8.
Katsumata Y, Kawasaki Y, Tanaka K, Nakayama D, Katayama H, Shimada S, et al.
Case Rep Oncol
. 2021 Dec;
14(3):1522-1529.
PMID: 34899246
Here, we discuss the safety and management of adverse events associated with pembrolizumab plus axitinib combination therapy for metastatic renal cell carcinoma in patients on hemodialysis. A 76-year-old man was...
9.
Mizuno K, Sumiyoshi T, Okegawa T, Terada N, Ishitoya S, Miyazaki Y, et al.
Clin Cancer Res
. 2021 Sep;
27(22):6164-6173.
PMID: 34526361
Purpose: Although cell-free DNA (cfDNA) testing is expected to drive cancer precision medicine, little is known about the significance of detecting low-frequency variants in circulating cell-free tumor DNA (ctDNA) in...
10.
Koyama J, Yamashita S, Yamada S, Fujii S, Goto T, Katayama H, et al.
Int J Urol
. 2020 Nov;
28(1):69-74.
PMID: 33131119
Objective: To evaluate the impact of cancer therapy on post-treatment ejaculation in patients with testicular cancer. Methods: A total of 74 testicular cancer survivors provided completed International Index of Erectile...